| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| IFB-H5253 | Human | Human IFN-alpha 2b (K46R) Protein, Fc Tag (MALS verified) |  |
|
|
Human IFN-alpha 2b (K46R), Fc Tag (Cat. No. IFB-H5253) immobilized on CM5 Chip can bind Human IFNAR2, His Tag (Cat. No. IF2-H5224) with an affinity constant of 0.257 μM as determined in SPR assay (Biacore T200) (Routinely tested).
The purity of Human IFN-alpha 2b (K46R), Fc Tag (Cat. No. IFB-H5253) is more than 90% and the molecular weight of this protein is around 95-105 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Recombinant human serum albumin-interferon-alpha-2a fusion protein (Qilu Pharmaceutical) | Phase 1 Clinical | Qilu Pharmaceutical Co Ltd, Institute Of Bioengineering Chinese Academy Of Military Medical Sciences | Hepatitis B, Chronic; Hepatitis B | Details | |
| SFR-9216 | SFR-9216 | Phase 1 Clinical | Tianjin Puying Biotechnology Co Ltd | Hepatitis B | Details |
| GSK-2245035 | GSK-2245035 | Phase 2 Clinical | Glaxosmithkline Plc | Rhinitis, Allergic, Seasonal; Rhinitis, Allergic; Asthma; Rhinitis | Details |
| SAR-441000 | SAR441000; SAR-441000; BNT-131 | Phase 1 Clinical | Biontech Se, Sanofi | Neoplasm Metastasis | Details |
This web search service is supported by Google Inc.
A-Z
